Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Quest Diagnostics Forecasts FY2024 Adjusted EPS Of $8.72-$8.97 Versus Prior Guidance Of $8.60-$8.90 And Consensus Of $8.75

Author: Benzinga Newsdesk | April 23, 2024 06:51am

Posted In: DGX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist